G11 SUPER GIO
123
02
PRACTICE MISSIONbiotechnology, statistical evidence, and ethics

biotechnology, statistical evidence, and ethics

NEW CASENEW EVIDENCE

CRISPR off-target evidence

Edited cells show 82% desired gene correction. Sequencing finds an unintended edit in 6% of cells at site Z; controls show 0.2%. Cell survival is unchanged over seven days.

  1. Efficacy and off-target risk both matter.
  2. Short survival follow-up does not establish long-term safety.
  3. Controls quantify background.

Which evaluation is justified?

MODELBioData Ethics File
DNA
PROVEChoose with evidence
CLUE

Pause. Find what matters. Then make your move.